PVLA EPS Estimates
Palvella Therapeutics, Inc.
$125.68
-$4.91(-3.76%)
41
Overall
40
Value
45
Tech
39
Quality
Market Cap
$1.88B
Volume
80.39K
52W Range
$59.16 - $161.38
Target Price
$229.19
PVLA EPS estimates: the consensus estimate for Palvella Therapeutics, Inc.'s current fiscal year is -$6.36 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
PVLA EPS Estimates
- EPS estimate, current quarter
- $-1.63
- EPS estimate, next quarter
- $-1.82
- EPS estimate, current year
- $-6.36
- EPS estimate, next year
- $-8.01
- EPS growth, 3-year
- -102.02%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.71 |
| 2024 | $-7.83 |
| 2023 | $-21.60 |
| 2022 | $-0.45 |
| 2021 | $-0.71 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PVLA | $125.68 | -3.8% | 80.39K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Palvella Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW